Vasogen was acquired by IntelliPharmaCeutics International on October 22, 2009
life science Company

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.

Join Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.

Vasogen, Inc.

4 Robert Speck Parkway 15th Floor,
Mississauga, Ontario ON L4Z 1S1
Canada,
(905) 817-2000

Vasogen, Inc. is a biotechnology company focused on destructive inflammatory processes associated with the development and progression of cardiovascular and neuro-inflammatory disorders.

Life Science M&A - Last 3 Years

Vasogen was acquired by IntelliPharmaCeutics International on October 22, 2009.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Vasogen.


What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.5K Private Equity Firms
  • 124K M&A Transactions
  • 134K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.9K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.